Calidi Biotherapeutics, Inc. — Form D
Calidi Biotherapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-21. The offering totals $65K, of which $33K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-03-21
- Form: D
- Accession: 0001855485-24-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $65K
- Amount sold: $33K
- Remaining: $33K
- Investors: 1
- Date of first sale: 2024-02-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508167
Issuer
- Name: Calidi Biotherapeutics, Inc.
- CIK: 0001855485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 4475 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
- Phone: 858-794-9600
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| James A Schoeneck | Director | San Diego, CA |
| George R Ng | Director | San Diego, CA |
| Boris Minev | Executive Officer | San Diego, CA |
| Scott R Leftwich | Director | San Diego, CA |
| Wendy Pizarro | Executive Officer | San Diego, CA |
| Alan R Stewart | Director | San Diego, CA |
| Andrew Jackson | Executive Officer | San Diego, CA |
| Allan Camaisa | Director | San Diego, CA |
| Allan Camaisa | Executive Officer | San Diego, CA |
| David A LaPre | Director | San Diego, CA |
Other filings by this issuer (5)
More